product summary
company name :
Cell Signaling Technology
product type :
gene knockdown
product name :
SignalSilence® Akt siRNA I
catalog :
6211
more info or order :
citations: 5
Reference |
---|
Bokobza S, Jiang Y, Weber A, Devery A, Ryan A. Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells. Oncotarget. 2014;5:4765-78 pubmed
|
Kierbel A, Gassama Diagne A, Mostov K, Engel J. The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell. 2005;16:2577-85 pubmed
|
Chandrasekar B, Mummidi S, Claycomb W, Mestril R, Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem. 2005;280:4553-67 pubmed
|
product information
SKU :
6211S
Product-Name :
SignalSilence® Akt siRNA I
Size :
300 ul
Price-(USD) :
240 USD
Species-x-Reactivity :
H, Hm, (M, R)
Product-Category :
PI3K / Akt Signaling
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
siRNA
MW :
60
Target :
Akt1/Akt2/Akt3
more info or order :
company information
Cell Signaling Technology
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
browse more products
questions and comments